All News

New board members

Pharmaceutical Representative welcomed two new members to its editorial advisory board in 1999: Mark Osborne, director of sales training at Chicago-based Searle and Professor Mickey Smith, professor of pharmacy administration and the director of the Center for Pharmaceutical Marketing and Management at the University of Mississippi.

On July 28, a district court judge in Washington ruled that some provisions of the FDA Modernization Act are unconstitutional because they violate pharmaceutical companies' rights to free speech.

Formulary is evidence-based

An "evidence-based formulary" that compares the safety, efficacy and cost of pharmaceuticals in the top eight therapeutic classes is being made available to clients of Express Scripts.

Minnesota HMOs still losing

Minnesota health maintenance organizations increased their average per-member premium revenue but continued to lose money, according to the recently released Minnesota Managed Care Review 1999.

Priorities motivate rep

For Searle's David Washco, it was a "very honorable and very humbling experience" - not to mention a big surprise - when the company named him its 1998 rep of the year.

Results from a new survey shed new light on how frequently health plans and care providers disagree about appropriate care for patients.

Targacept targets nicotine

RJR Tobacco Co., long known for its cigarette products, is turning its knowledge of nicotine into compounds that fight Alzheimer's and Parkinson's diseases.

Investor-owned health maintenance organizations fall short of non-profit HMOs in 14 quality-of-care indicators, according to a recent study published in the Journal of the American Medical Association.

When asking doctors whether or not they have been prescribing a drug, specialty sales rep David Schwartz's advice is, "Don't accept yes or no for an answer."

Swiss pharmaceutical manufacturer Hoffman-La Roche Ltd. plead guilty to an extensive global price-fixing conspiracy surrounding vitamins, the U.S. Department of Justice announced.

The boards of directors of the French firms Sanofi and Synthélabo presented a plan to each company's shareholders to merge the two companies into Sanofi-Synthélabo.

Ortho-McNeil Pharmaceuticals funded a survey that revealed more recent perceptions about pain and pain management.

Primary care appears to offset the negative health effects of poverty, according to researchers at the Johns Hopkins School of Public Health.

More than one-third of patients do not tell their physicians all of the prescription and over-the-counter medications that they are taking.

When you notice that a star employee is not performing like he or she used to, what should you do?

As part of an effort to assume full promotional responsibility for two popular anti-infective products, Dura Pharmaceuticals announced plans to add an acute care division to its sales force.

There were five main techniques applied by the managed care industry in an effort to stem pharmaceutical costs in recent years, according to the "1999 Pharmaceutical Industry Profile" published by the Pharmaceutical Research and Manufacturers of America.